US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 16, 2021 (5 years ago)

Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

What was recalled

Minivelle (estradiol transdermal system) Delivers 0.075 mg/day, 8 patches/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-6675-8

Recalling firm
Noven Pharmaceuticals Inc
NDC code
68968-6675-8
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0336-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Estradiol recalls

See all